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Abstract: Symmetrical peripheral gangrene (SPG) is a rare entity characterized by ischemic changes
of the distal extremities with maintained vascular integrity. We present the case of a 64-year-old
man with bilateral necrotic toes and deranged liver function tests. This was thought to be related to
severely depressed ejection fraction from non-ischemic etiology, presumably chronic alcohol ingestion.
We hope that awareness of SPG and association with a low output state will aid in early detection
and prevention.
Keywords: symmetrical peripheral gangrene; heart failure; low flow state
1. Introduction
Symmetrical peripheral gangrene (SPG) was first described by Hutchison in 1891 [1]. SPG is a rare
clinical condition with acute, symmetrical ischemia of two or more extremities, leading to gangrene
in the absence of large vessel obstruction or vasculitis [2–5]. Various infective and noninfective
factors are responsible for the development of SPG [3]. Among them, cardiac conditions myocardial
infarction [6–8], myocardial infarction with coronary artery bypass graft and, such as ventricular septal
defect repair [9], paroxysmal ventricular tachycardia [10], ventricular pseudoaneurysm [11], and severe
heart failure [12] have been associated with SPG. We present a case of SPG in the setting of severely
depressed cardiac ejection fraction.
2. Case Description
Our patient is a 64-year-old man referred to our emergency department from an outside hospital
for management of liver failure and bilateral necrotic toes. The patient was confused at the time of
presentation and was not able to provide a detailed history. He was accompanied by his niece, who
explained that the patient had had intermittent episodes of confusion over the past several days prior
to presentation. He was taken to the referring hospital because his niece had noticed discoloration
of his toes and progressive yellowing of the skin. As the patient’s mentation got better during the
hospital stay, he mentioned that he had had nausea, vomiting, diarrhea, and abdominal pain for three
months prior to admission. He does not remember being out in the cold. He denied recent medications,
including antibiotics, herbal supplement use, and drug use, and he also denied recent travel and tick
bites. He did not have any urinary complaints. He did not have dyspnea, orthopnea, chest pain, a
change in exercise tolerance, or pedal edema. His past medical history was significant due to a motor
vehicle accident with a traumatic brain injury, complex regional pain syndrome, a prostate carcinoma
status post-transurethral resection of the prostate, depression, and hypertension. He was never told
he had liver or heart problems. His home medications were aspirin, hydrochlorothiazide, irbesartan,
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duloxetine, gabapentin, clonazepam, and tramadol. He smoked a few cigarettes per day but had been
up to a pack per day for 4–5 years in total alongside marijuana use. Upon questioning, he stated that
he drank 3–4 beers and 2–3 glasses of liquor daily. Later, his son mentioned that he had found multiple
empty bottles of liquor prior to admission. The patient lived independently in his apartment and was
able to take care of himself. He reported good exercise tolerance without any anginal symptoms.
At presentation, his temperature was 98 ◦F (36.7 ◦C), his pulse was 103 beats per min, his blood
pressure was 107/84 mm Hg, and his respiratory rate was 17 per min, maintaining saturation at 96% on
room air. He was icteric on examination. He had sparse bibasilar rales on chest examination. Cardiac
examination was suggestive of parasternal heave with an enlarged point of maximal impulse. He had
dry and gangrenous second through fifth toes and densely cyanotic first toes, bilaterally (Figure 1).
This subsequently progressed to necrosis of all his toes. He did not have any other skin or mucous
membrane changes. His bilateral dorsalis pedis and posterior tibialis pulses were palpable.
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His electrocardiogram (EKG) showed sinus tachycardia with a left bundle branch block with 
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fraction of 10% with global hypokinesis and severe left ventricular enlargement but no embolus. His 
brain-type natriuretic peptide (BNP) was 18,984 pg/mL (reference range: 0–100 pg/mL). Troponin and 
thyroid stimulating hormones were within normal ranges. A left heart catheterization showed non-
obstructive coronary artery disease. A right heart catheterization showed elevated pulmonary artery 
pressures and filling pressures with a cardiac index of 1.28 L/min/sqm. The patient was started on 
dobutamine infusion for inotropic support. His cardiomyopathy was thought to be related to alcohol 
intake because the patient had been consuming moderate amounts of alcohol for more than 20 years. 
He was also put on lisinopril for afterload reduction. The patient improved clinically in the next five 
days and was weaned off dobutamine. He was not thought to be a candidate for a heart transplant 
or advanced therapies based on ongoing alcohol abuse or lack of social support.  
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4. Liver Failure
His liver function tests at the referring hospital were deranged (Table 1), which was eventually
thought to be secondary to the reduced cardiac index with hypoperfusion of liver and chronic alcohol
abuse. His liver function tests improved with clinical improvement and initiation of dobutamine.
Computerized tomography (CT) of abdomen/pelvis was consistent with hepatic steatosis. Viral
hepatitis panels, Tylenol levels, anti-mitochondrial antibodies, liver kidney microsomal antibodies,
and anti-smooth muscle antibodies for autoimmune hepatitis, and ceruloplasmin for Wilson’s disease
were negative (Table 1).
Table 1. Pertinent labs with reference ranges.
S.N. Labs
Outside Referring
Hospital or on
Admission
Prior to Discharge Normal ReferenceRanges
1. Liver function test
a. Bilirubin, total 35.0 9.0 0.1–0.9 mg/dL
b. Bilirubin, direct >10.0 6.2 0.0–0.3 mg/dL
c. Aspartate aminotransferase 309 192 7–42 IU/L
d. Alanine aminotransferase 295 172 <45 IU/L
e. Alkaline phosphatase 120 237 25–120 IU/L
f. Albumin 3.0 2.6 3.2–4.9 g/dL
g. Ammonia 39 11–35 µmol/L
2. Coagulation panel
a. International normalized ratio 1.37 1.30 0.81–1.19
b. Prothrombin time 15.2 14.4 8.9–13.1 sec
c. Partial thromboplastin time 30 31 24–35 sec
d. Platelet count 229 140–400 109/L
3. Renal function test
a. Sodium 131 135–146 mmol/L
b. Potassium 4.0 3.3–4.8 mmol/L
c. Chloride 97 89–109 mmol/L
d. Bicarbonate 20 24–32 mmol/L
e. Blood urea nitrogen 23 10–26 mg/dL
f. Creatinine 0.9 0.7–1.7 mg/dL
4. Workup for etiology
a. HBsAg Negative Negative
b. HBCAb Negative Negative
c. Hep A, IgM Negative Negative
d. HCV Ab Negative Negative
e. HIV Ab/p24 Ag Negative Negative
f. HSV IgM Negative Negative
g. VZV IgM Negative Negative
h. Alcohol <0.01 <0.01 g/dL
i. Acetaminophen Negative Negative
j. Anti-mitochondrial antibody Negative Negative
k. Liver kidney microsomal antibody Negative Negative
l. Anti-smooth muscle antibody Negative Negative
m. Ceruloplasmin Negative Negative
5. Necrotic Toes
His white count was slightly elevated at 12,500/µL (reference range: 4000–11,000/µL).
His erythrocyte sedimentation rate (ESR) was 25 mm/h (reference range: 0–15 mm/h) and his C-reactive
protein (CRP) was 6.20 mg/dL (reference range: ≤0.80 mg/dL). His ESR and CRP were believed to
be elevated secondary to the gangrene. CT angiography of the chest/abdomen/pelvis showed patent
aorta and branch vessels without significant stenosis. Doppler ultrasound of legs showed normal
ankle-brachial index and ankle waveforms. Rheumatology was also consulted to rule out vasculitis as
a potential cause of his presentation; however, his workup was negative. His necrosis was thought to
be secondary to the decreased peripheral perfusion and redistribution to vital organs in the setting of
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acute heart failure. Skin biopsy was not done for concern for risk of infection. The patient was planned
for an outpatient podiatry follow-up for possible amputation but was lost to the follow up.
6. Ethical Statement
Informed consent was obtained from the patient for submission of the case.
7. Discussion
7.1. Pathogenesis
The exact mechanism for SPG is unclear [3]. A hypercoagulable disseminated intravascular
coagulation (DIC)-like condition secondary to sepsis has been associated in 85 to 100% of patients with
SPG [4,11]. Our patient was not septic on presentation and did not have a clear source of infection that
might have led to DIC. In the case of severe right heart failure, Fishberg et al. first noted engorged
jugular veins and elevated jugular venous pressure with collapsed veins of extremities occurring
reflexively to redistribute blood supply to essential organs, such as the brain [13]. With decreased
peripheral perfusion pressures from 36 to 60 mm Hg, blood flow through digital arteries stops [2,14].
Low flow state combined with microvascular occlusion from DIC [3,15] leads to ischemic changes that
involve distal extremities and advances, proximally [3]. Aggravating factors include cold-induced
vasospasm [2,11], the use of vasoconstrictor drugs [2,3], diabetes mellitus, and renal failure [2].
7.2. Clinical Presentation
The exact incidence of SPG is not known [3]. Studies have reported both male [16] and female [17]
preponderance. SPG initially presents with cold and pale extremities followed by dusky discoloration
of the skin [2–4]. This progressively worsens to dry gangrene in 12–24 h with the formation of a
line of demarcation in about two weeks. Peripheral pulses are palpable except in cases with the use
of vasoconstrictor medications. Ear lobes, upper lip, scalp, genitalia, and the tip of the nose can be
involved in severe cases [4]. Our patient had gangrenous involvement of only his toes.
7.3. Diagnosis
A diagnosis should be suspected in patients with bluish discoloration of extremities and elevated
lactate levels. Presence of schistocytes on a peripheral smear may indicate microangiopathic changes
from DIC. However, DIC may occur late, and repeated screening should be done. Doppler ultrasound
of the extremities shows intact peripheral pulses [3,9]. Cohen et al. noted that sections taken from the
left dorsalis pedis artery were non-occluded in patients with SPG [9]. Post-mortem examinations have
also found occlusion of the small vessels [2].
7.4. Management
Treatments for these patients are largely anecdotal and have not been shown to improve or
reverse the gangrene. Every effort should be made to identify and treat the underlying cause [3].
Early recognition of SPG, hemodynamic stability using intravenous fluids, and management of DIC
are central to management [2,4]. Vasopressors should be avoided as they can worsen this condition.
Repletion of coagulation factors or use of anticoagulants, based on whether bleeding or thrombosis is
predominant, can help [3]. Sympathetic blockades, vasodilators, such as intravenous nitroprussides,
local or intravenous infusion of a-blockers (phentolamine, chlorpromazine), and intravenous infusion
of prostaglandin (epoprostenol) may be helpful. Ultimately, amputation of the gangrenous area after
the appearance of a line of demarcation may be required [2,3]. Our patient was managed for heart
failure with inotropes and diuretics. We did not place him on vasodilators with fear for decompensation
of heart failure.
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7.5. Prognosis
Prognosis is poor with mortality in one-tenth [17] to one-third of affected patients [16,18].
Most deaths occurred within 5 to 21 days after the onset of gangrene [18]. Of surviving cases,
amputation (auto-amputation or surgical amputation) was reported in 67% [18] and 89% [16]. Thus,
the development of SPG is an ominous prognostic sign, particularly in the background of DIC.
8. Conclusions
SPG is associated with significant mortality and morbidity with an alarmingly high rate of
amputation in survivors. Awareness of this condition and association with a low flow state can help
diagnose this condition early with prompt treatment for early recovery.
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